Main menu


You are here

Research

For older patients, Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief --two new studies

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.

Benefit seen only in older patients

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Analysis: Can one die from long COVID? The answer is not so simple

...

While long COVID is not usually immediately or directly life-threatening, it’s possible it could exacerbate existing conditions, and play a role in a person’s death in this way.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks
Page loaded in 0.693 seconds.